期刊文献+

白介素-18在慢性丙型肝炎患者中的表达及意义研究 被引量:1

Expression level and significance of interleukin-18 in patients with chronic hepatitis C
下载PDF
导出
摘要 目的了解慢性丙型肝炎(CHC)患者血清白介素-18(IL-18)与丙型肝炎病毒抗体(HCV-Ab)、病毒载量、丙氨酸氨基转移酶(ALT)的关系,探讨IL-18在CHC患者中的表达情况与临床意义。方法收集2012年12月至2013年4月广西医科大学第一附属医院门诊及病区就诊的47例CHC患者为CHC患者组,检测IL-18、病毒载量、HCV-Ab、ALT,分析丙型肝炎病毒阳性、阴性,HCV-Ab阳性、阴性以及不同ALT浓度患者IL-18的表达情况。另纳入同期高校体检学生20例为健康对照组,分析CHC患者与健康体检者IL-18的表达情况。结果 CHC患者组与健康对照组相比,IL-18浓度显著升高,差异有统计学意义(P<0.01)。IL-18在HCV-RNA阳性与阴性、HCV-Ab阳性与阴性间表达差异均无统计学意义(P>0.05);血清ALT水平与IL-18水平相关性分析,结果无明显相关性(r=0.291,P>0.05)。结论 IL-18与HCV慢性感染有关,但与HCV复制及其所致的肝损伤无明显相关性。 Objective To explore the relationship of hepatitis C virus (HCV)-antiboby(Ab) ,viral load ,ala-nine aminotransferase (ALT) with interleukin-18 respectively ,and to discuss the expression level and clinical signifi-cance of IL-18 in patient with chronic hepatitis C (CHC) .Methods Blood serum and clinical datum of patients with CHC were collected ,who receiving treatment in outpatient and inpatient detpatment of this hospital from Dec .2012 to Apr .2013 .Serum concentration of IL-18 ,viral load ,HCV-Ab and ALT were detected .Expression level of IL-18 in patients of HCV-RNA(+ ) group ,HCV-RNA(-) group ,HCV-Ab(+ ) group and HCV-Ab(-) group and patients with different concentrations of ALT were compared .A total of 20 cases of healthy students in university were en-rolled as control group .Then the expression levels of IL-18 in patients with CHC and healthy subjects were com-pared .Results The concentration of IL-18 in CHC group increased significantly compared with control group (P&lt;0 .01) .There was no statistically significant difference of concentration of IL-18 between HCV-RNA(+ ) group and HCV-RNA(-) group ,as well as between HCV-Ab(+ ) group and HCV-Ab(-) group (P&gt;0 .05) .There was no significant correlation between level of IL-18 and ALT (r=0 .291 ,P&gt;0 .05) .Conclusion IL-18 might be associated with chronic HCV infection ,but could be not significantly correlated with HCV replication and hepatic lesion caused by the latter .
出处 《检验医学与临床》 CAS 2014年第6期742-743,746,共3页 Laboratory Medicine and Clinic
基金 广西医疗卫生适宜技术研究与开发课题资助项目(桂卫S201304-01)
关键词 慢性丙型肝炎 发病机制 白介素-18 INTERLEUKIN-18 chronic hepatitis C pathogenesis
  • 相关文献

参考文献12

  • 1Lavanchy D. The global burden of hepatitis cD], Liver Int,2009,29(Sl):74-81.
  • 2Cui Y ,]iaJ. Update on epidemiology of hepatitis Band C in China[J].] Gastroenterol Hepatol , 2013. 28(Sl) : 7-10.
  • 3Verardi PH. Legrand FA, Chan KS, et al. IL-18 Expres?sion Results in a Recombinant Vaccinia Virus That Is Highly Attenuated and Immunogenic[J].J Interferon Cy?tokine Res, 2013,29(10) : 1-10.
  • 4丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 5Zhao BB, Zheng SJ, Gong LL, et al. T lymphocytes from chronic HCV-infected patients are primed for activation?induced apoptosis and express unique pro-apoptotic gene signature[J]. PLoS One,2013,8(lO) ,e77008.
  • 6Gigi E, Raptopoulou-Gigi M, Kalogeridis A, et al. Cyto?kine mRNA expression in hepatitis C virus infection: THI predominance in patients with chronic hepatitis C and THl- TH2 cytokine profile in subjects with self-limited diseasej]"].J Viral Hepat , 2008,15 (2) : 145-154.
  • 7Yue M, WangJ J, Tang SD, et al. Association of inter?leukin-18 gene polymorphisms with the outcomes of hepa?titis C virus infection in high-risk chinese Han population[J]. Immunol Lett,2013, 154(1-2) :54-60.
  • 8张琳,苗亮,付海超,赵桂珍,冯国和,窦晓光.慢性丙型肝炎患者血清IL-18和IL-1β水平的变化及意义[J].世界华人消化杂志,2009,17(20):2105-2111. 被引量:4
  • 9Schvoerer E, Navas MC, Thumann C, et al. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy[J].J Med Virol , 2003, 70( 4) : 588-593.
  • 10Majda-Stanislawska E, Pietrzak A, Brzezinska-Blaszczyk E. Serum IL-18 concentration does not depend on the presence of HCV-RNA in serum or in PBMC[J]. Hepa?togastroenterology , 2008,55(81) :212-215.

二级参考文献29

  • 1Zaigham Abbas,Tariq Moatter,Akber Hussainy,Wasim Jafri.Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3[J].World Journal of Gastroenterology,2005,11(42):6656-6661. 被引量:7
  • 2Bouzgarrou N, Hassen E, Schvoerer E, et al. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection [J]. J Med Virol, 2008,80(4) :607-614.
  • 3Gigi E, Raptopoulou-Gigi M, Kalogeridis A, et al. Cytokine mR- NA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease [J]. J Viral Hepat, 2008,15 (2) : 145-154.
  • 4Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells [ J ]. Nature, 1995,378(6552) :88-91.
  • 5Falasca K, Ucciferri C, Dalessandro M, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C [J]. Ann Clin Lab Sci, 2006,36(2):144-150.
  • 6Sharma A, Chakraborti A, Das A, et al. Elevation of interleukin- 18 in chronic hepatitis C: implicationsfor hepatitis C virus pathogenesis [J]. Immunology, 2009,128(1 Suppl):e514-522.
  • 7Vecchiet J, Falasca K, Cacciatore P, et al. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease [J]. Ann Clin Lab Sci, 2005, 35(4) :415-422.
  • 8Komano T, Egashira Y, Sanada H. L-GIn and L-Set suppress the D-galactosamine-induced IL-18 expression and hepatitis [J ]. Biochem Biophys Res Commu n, 2008,372 ( 4 ) : 688-690.
  • 9Yoshida T, Abe K, Ikeda T, et al. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury [J]. EurJ Pharmacol, 2007,576(1-3) :136-142.
  • 10Tsutsui H, Matsui K, Okamura H, et al. Pathophysiological roles of interleukin-18 in inflammatory liver diseases [J ]. Immunol Rev, 2000,174 : 192-209.

共引文献736

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部